Skip to contentK
Kraig Biocraft Laboratories, Inc.
K
KBLBKraig Biocraft Laboratories, Inc. Q4 2014 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$0.00$0.00derivedno prior Q4 2013 on file Net Income-$419.66K-$419.66KderivedN/M vs Q4 2013 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Kraig Biocraft Laboratories, Inc. · CIK 1413119 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Operating Incomederived-$414,297N/M Free Cash Flowderived-$230,739— ended Dec 31, 2014 · filed Mar 31, 2015 · 90 d after period end